On Monday, Sangamo Therapeutics Inc (NASDAQ: SGMO) opened lower -1.14% from the last session, before settling in for the closing price of $0.73. Price fluctuations for SGMO have ranged from $0.30 to $3.18 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 0.15% over the last five years. Company’s average yearly earnings per share was noted 44.04% at the time writing. With a float of $214.84 million, this company’s outstanding shares have now reached $224.71 million.
The firm has a total of 183 workers. Let’s measure their productivity. In terms of profitability, gross margin is 87.48%, operating margin of -169.24%, and the pretax margin is -169.74%.
Sangamo Therapeutics Inc (SGMO) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Sangamo Therapeutics Inc is 4.39%, while institutional ownership is 27.79%.
Sangamo Therapeutics Inc (SGMO) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 44.04% per share during the next fiscal year.
Sangamo Therapeutics Inc (NASDAQ: SGMO) Trading Performance Indicators
Check out the current performance indicators for Sangamo Therapeutics Inc (SGMO). In the past quarter, the stock posted a quick ratio of 1.13. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.52, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.35 in one year’s time.
Technical Analysis of Sangamo Therapeutics Inc (SGMO)
Analysing the last 5-days average volume posted by the [Sangamo Therapeutics Inc, SGMO], we can find that recorded value of 2.47 million was lower than the volume posted last year of 6.34 million. As of the previous 9 days, the stock’s Stochastic %D was 26.51%. Additionally, its Average True Range was 0.08.
During the past 100 days, Sangamo Therapeutics Inc’s (SGMO) raw stochastic average was set at 8.42%, which indicates a significant decrease from 29.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 73.92% in the past 14 days, which was lower than the 170.58% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8190, while its 200-day Moving Average is $1.1998. Now, the first resistance to watch is $0.7412. This is followed by the second major resistance level at $0.7624. The third major resistance level sits at $0.7826. If the price goes on to break the first support level at $0.6998, it is likely to go to the next support level at $0.6796. Should the price break the second support level, the third support level stands at $0.6584.
Sangamo Therapeutics Inc (NASDAQ: SGMO) Key Stats
There are currently 229,193K shares outstanding in the company with a market cap of 161.79 million. Presently, the company’s annual sales total 57,800 K according to its annual income of -97,940 K. Last quarter, the company’s sales amounted to 7,550 K and its income totaled -23,400 K.
